Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Top 5 Ways To Leverage eLogs In Clinical Research
Unearth how embracing these specific approaches ensures that technology becomes a true ally in enhancing precision, accessibility, and collaboration within the intricate realm of clinical research.
-
Shaping The Future Of eCOA User Acceptance Testing
Proactive planning by sponsors and early User Acceptance Testing (UAT) involvement in the eCOA design process can substantially improve study quality, efficiency, and consistency.
-
Reflexion Counts On Medrio To Launch First Studies
Learn how a therapeutic oncology company was able to take advantage of an EDC system, establish a ePRO assessments collections platform, and receive guidance on data collection devices.
-
Accelerating Clinical Data Review With Traceable Workflows
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Let's Talk About The TMF Trinity
Explore the three things that all studies try to achieve with their trial master file, and how the accelerated usage of the eTMF helps to both manage and meet these expectations.
-
How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia
Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.
-
Investigator Databank And DQS: Welcoming New Consortium Members
Join the Data Query System consortium to access a comprehensive, collaborative platform that enhances clinical trial feasibility, site selection, and investigator engagement.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Oncology Trials: Accuracy And Alleviating The Patient Screening Burden
Flatiron Health has unveiled an innovative service designed to enhance patient screening for clinical trials by integrating structured EHR data with machine learning and human analysis.
-
eCOA Predictions For 2022
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
FROM THE EDITOR
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders